This inventor holds 1 USPTO granted patent. Top assignee: Betta Pharmaceuticals Co., Ltd.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Bo Zhan - Innovator in ERK Inhibition
Introduction
Bo Zhan is a prominent inventor based in Zhejiang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific biological pathways.
Latest Patents
Bo Zhan holds a patent for an ERK inhibitor and its use. The patent discloses a compound that acts as an extracellular signal-regulated kinase (ERK) inhibitor. This compound is crucial in treating ERK-mediated diseases. It plays a role in regulating various processes such as cell proliferation, apoptosis, migration, and angiogenesis. His innovative work in this area has the potential to impact therapeutic strategies significantly.
Career Highlights
Bo Zhan is associated with Betta Pharmaceuticals Co., Ltd., where he continues to advance his research and development efforts. His work is characterized by a commitment to improving health outcomes through innovative pharmaceutical solutions.
Collaborations
He collaborates with notable colleagues, including Hao Wu and Wei Gu, who contribute to his research endeavors and help drive forward the mission of their organization.
Conclusion
Bo Zhan's contributions to the field of ERK inhibition exemplify the impact of innovative thinking in pharmaceuticals. His work not only advances scientific knowledge but also holds promise for future medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile